IK-930 is a novel TEAD inhibitor for the treatment of cancers harboring mutations in the Hippo signal transduction pathway Benjamin S. Amidon,Marta Sanchez-Martin,Wilmin Bartolini,Sakeena Syed,Karen McGovern, Lan Xu,Jeffrey Ecsedy,X. Michelle Zhang,Alex Constan,Alfredo C. CastroCANCER RESEARCH(2022)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要